Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory Markers in Statin Treated Patients With Persistent High Triglycerides and Chronic Kidney Disease Submitted by amarin on Fri, 12/08/2017 - 04:50 Home Read more about Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory Markers in Statin Treated Patients With Persistent High Triglycerides and Chronic Kidney Disease
Amarin Reaches the Onset of Approximately 80% of the Target Aggregate Number of Primary Major Adverse Cardiovascular Events Within the REDUCE-IT Study Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Reaches the Onset of Approximately 80% of the Target Aggregate Number of Primary Major Adverse Cardiovascular Events Within the REDUCE-IT Study
Amarin Corporation CEO, John Thero, to Chair the American Heart Association's Heart & Stroke Ball in New York City Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Corporation CEO, John Thero, to Chair the American Heart Association's Heart & Stroke Ball in New York City
Amarin to Report First Quarter 2017 Results and Host Conference Call on May 3, 2017 Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin to Report First Quarter 2017 Results and Host Conference Call on May 3, 2017
Amarin Reports First Quarter 2017 Financial Results and Provides Update on Operations Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Reports First Quarter 2017 Financial Results and Provides Update on Operations
Amarin Announces Expanded Research Relationships and Studies to Help Improve Cardiovascular Care Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Announces Expanded Research Relationships and Studies to Help Improve Cardiovascular Care
Amarin to Present at the Jefferies 2017 Global Healthcare Conference Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin to Present at the Jefferies 2017 Global Healthcare Conference
Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid Parameters in Statin-Treated Women With Type 2 Diabetes and Persistent High Triglycerides Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid Parameters in Statin-Treated Women With Type 2 Diabetes and Persistent High Triglycerides
Amarin to Report Second Quarter 2017 Results and Host Conference Call on August 2, 2017 Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin to Report Second Quarter 2017 Results and Host Conference Call on August 2, 2017
Amarin Reports Second Quarter 2017 Financial Results and Provides Update on Operations Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Reports Second Quarter 2017 Financial Results and Provides Update on Operations
